Suchergebnisse - "Geretti, Anna Maria"

PubPharm (316)

51

Corrigendum : Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity Setting

enthalten in: Open forum infectious diseases | 2019

von Abdullahi, A. | Fopoussi, O. | Torimiro, J. | +3

ErratumFor: Open Forum Infect Dis. 2018 Oct 05;5(10):ofy251. - PMID 30377627

52

Being part of the solution

enthalten in: Sexually transmitted infections | 2019

von Geretti, A.

53

Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2019

von Geretti, A. | White, E. | Orkin, C. | +7

54

Clinical use, efficacy, and durability of maraviroc for antiretroviral therapy in routine care : A European survey

enthalten in: PloS one | 2019

von De Luca, A. | Pezzotti, P. | Boucher, C. | +10

55

Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring

enthalten in: The Journal of antimicrobial chemotherapy | 2018

von Villa, G. | Phillips, R. | Smith, C. | +7

56

Point-of-Care Screening for a Current Hepatitis C Virus Infection : Influence on Uptake of a Concomitant Offer of HIV Screening

enthalten in: Scientific reports | 2018

von Geretti, A. | Austin, H. | Villa, G. | +7

57

Epidemiology of hepatitis B, C and D in Malawi : systematic review

enthalten in: BMC infectious diseases | 2018

von Stockdale, A. | Mitambo, C. | Everett, D. | +2

58

Epidemiology of hepatitis B, C and D in Malawi: systematic review

enthalten in: BMC infectious diseases | 2018

von Stockdale, A. | Mitambo, C. | Everett, D. | +2

59

Epidemiology of hepatitis B, C and D in Malawi: systematic review

enthalten in: BMC infectious diseases | 2018

von Stockdale, A. | Mitambo, C. | Everett, D. | +2

60

Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity Setting

enthalten in: Open forum infectious diseases | 2018

von Abdullahi, A. | Fopoussi, O. | Torimiro, J. | +3

ErratumIn: Open Forum Infect Dis. 2019 Apr 03;6(4):ofz142. - PMID 30968060